OTTAWA: Canadian Minister of Health Rona Ambrose Tuesday announced the launch of Phase 1 clinical trials in human for Canada's Ebola vaccine (VSV-EBOV) at the Walter Reed Army Institute of Research in Silver Spring, the U.S. state of Maryland.
The Phase 1 clinical trial will test the vaccine on a small group of people to determine whether the vaccine is safe and the appropriate dose necessary to provide immunity, said Ambrose in a press release.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.